ModeX Therapeutics Inc., an OPKO Health company, announced the formation of a Scientific Advisory Board to support the development of its immunology and oncology pipeline, which includes ...
Patients dosed in Phase 1 safety and tolerability study of MDX2003, a novel T-cell engager designed to optimize killing of lymphomas Preclinical studies presented at 2025 American Society of ...
Amazon Supply Chain Services launch signals major shift for freight transportation and logistics The recent announcement by Seattle-based global e-commerce giant Amazon regarding the official opening ...
Will provide expertise across ModeX’s portfolio of next generation multispecific antibodies for complex diseases involving the immune system, including cancer ModeX’s promising immunology pipeline ...
Earnings call OPKO Health reported Q4 2025 revenue of $148.5 million, down from $183.6 million YoY due to the Labcorp oncology asset sale, but achieved margin improvement and cost reductions. The ...
Opko Health Inc. (NASDAQ:OPK) is one of the best stocks under $5 with highest upside potential. ModeX Therapeutics Inc., an Opko Health Inc. (NASDAQ:OPK) company, announced on October 29 a license and ...
ATLANTA--(BUSINESS WIRE)--Every industry has its must-attend event—the one gathering that sets the tone for innovation, networking, and strategy for the year ahead. For the supply chain, that event is ...
We recently compiled a list of the 12 Healthcare Stocks with Insider Buying in 2025. OPKO Health, Inc. is one of them. OPKO Health, Inc. (NASDAQ:OPK) is a diversified healthcare company with ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results